Surgery Partners, Inc.

Surgery Partners, Inc. announced its first quarter 2026 results, reporting a 4.5% increase in revenue to $810.9 million and a net loss attributable to the company of $35.9 million. Adjusted EBITDA for the quarter was $102.3 million. The company reaffirmed its full-year 2026 guidance, projecting revenue between $3.35 billion and $3.45 billion and Adjusted EBITDA of at least $530 million, signaling confidence in its operational performance and strategic initiatives.

Surgery Partners reported its first-quarter 2026 results, with revenue increasing 4.5% to $810.9 million and same-facility revenues growing 4.4%. The company posted a net loss attributable to Surgery Partners of $35.9 million and Adjusted EBITDA of $102.3 million. Management expressed encouragement with the solid start to 2026 and reaffirmed its full-year 2026 revenue guidance of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, citing confidence in returning to consistent growth.

Surgery Partners, Inc. announced it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. This will be followed by a conference call at 8:30 a.m. Eastern Time to discuss the results. Investors can access the call via dial-in numbers or a live webcast on the company's investor relations website, with a replay available until May 19, 2026.